US courts disagree on generic drug exclusivity

被引：0
|
作者：
Ken Chahine
机构：
[1] a patent attorney in Salt Lake City,
来源：
Nature Biotechnology | 1998年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：132 / 132
相关论文
共 50 条
  • [41] US branded drug makers pay to prevent generic competition
    Hopkins-Tanne, Janice
    BRITISH MEDICAL JOURNAL, 2008, 336 (7656): : 1266 - 1267
  • [42] Will inter partes review speed US generic drug entry?
    Darrow, Jonathan J.
    Beall, Reed F.
    Kesselheim, Aaron S.
    NATURE BIOTECHNOLOGY, 2017, 35 (12) : 1139 - 1141
  • [43] FDA: Approval of generic drug reversed by US court of appeals
    Beliveau, S
    JOURNAL OF LAW MEDICINE & ETHICS, 2002, 30 (01): : 120 - 122
  • [44] Public outcry over US generic drug price hikes
    Furlow, Bryant
    Lancet Respiratory Medicine, 2015, 3 (11): : 840 - 840
  • [45] US Food and Drug Administration Disruption of Generic Drug Market Increases Hospital Costs
    Almeter, Philip J.
    Labuhn, Jonathan A.
    Morris, Peter E.
    Hessel, Eugene A., II
    ANESTHESIA AND ANALGESIA, 2018, 127 (06): : 1414 - 1420
  • [46] SELL A NEARLY-MATURED ENDOWMENT - COURTS DISAGREE ON CAPITAL GAIN
    不详
    JOURNAL OF TAXATION, 1958, 9 (06): : 370 - 371
  • [47] WHEN COURTS AND EXPERTS DISAGREE - DISCORDANCE BETWEEN INSANITY RECOMMENDATIONS AND ADJUDICATIONS
    HOWARD, RC
    CLARK, CR
    LAW AND HUMAN BEHAVIOR, 1985, 9 (04) : 385 - 395
  • [48] Canada's courts and government disagree on assisted dying as deadline looms
    Dyer, Owen
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [49] ARE DIVERSIONS OF CORPORATE FUNDS TAXABLE WHEN NO E AND P - COURTS DISAGREE
    CLURMAN, H
    JOURNAL OF TAXATION, 1966, 25 (02): : 92 - 94
  • [50] Updated trends in US brand-name and generic drug competition
    Grabowski, Henry
    Long, Genia
    Mortimer, Richard
    Boyo, Ani
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (09) : 836 - 844
12345